Question follow-through · 110858
Life Sciences
To ask the Secretary of State for Health and Social Care, with reference to the correspondence from the Minister for Science, Innovation, Research and Nuclear to the Chair of the Science, Innovation and Technology Committee, dated 30 January 2026, if he w
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 4 Feb 2026
- Target answer date
- 9 Feb 2026
- Answer
- 9 Feb 2026 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
4 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, with reference to the correspondence from the Minister for Science, Innovation, Research and Nuclear to the Chair of the Science, Innovation and Technology Committee, dated 30 January 2026, if he w
9 Feb 2026
Target answer date
Date supplied by the official written-questions record.
9 Feb 2026
Answer published
There are no current plans to publish the joint analysis undertaken by the Department, NHS England, and the National Institute for Health and Care Excellence (NICE) on the cost of the United Kingdom and United States’ pharmaceutical trade deal.Tens of tho...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.